Inovio Pharmaceuticals, Inc. (NYSE MKT: INO)
Dr. Joseph Kim discusses with Equities.com discuses the potential of synthetic vaccines and immune therapies for cancers and infectious diseases.
This video interview may include forward-looking statements that involve risks and uncertainties. Forward- looking statements are statements that are not historical facts and are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. To read our full disclosure, please go to: http://www.equities.com/disclaimer.
- Panna Sharma of Cancer Genetics joins...
- Published on 02 October 2013
- Views (583)
- Seth Grae of Lightbridge Corp. sits...
- Published on 19 September 2013
- Views (734)
- Robert Newman of Newman & Morrison...
- Published on 28 May 2013
- Views (786)
- Cash Store Financial Services's CEO...
- Published on 08 November 2011
- Views (636)
|Today's Must Reads|
|Global Winners and Losers in the Oil Shakeout|
|This Bull Market is No Stranger to Big Fourth-Quarter Comebacks|